A Relative Bioavailability Study of Propranolol Hydrochloride 160 mg Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is TO compare the relative bioavailability of Propranolol
Hydrochloride Extended Release Capsules 160 mg (Actavis) with that of INDERAL® LA 160 mg
Capsules (Wyeth Pharmaceuticals) following a single oral dose (1 x 160 mg) in healthy adult
volunteers under fasting conditions.